PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.35% | 13.43% | 4.90% | 16.01% | -13.28% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -76.17% | 64.64% | 59.30% | -200.69% | 292.53% |
| Total Other Non-Cash Items | 745.27% | -20.65% | -2.24% | 12.43% | -78.28% |
| Change in Net Operating Assets | 332.34% | 159.29% | 178.75% | 120.58% | 56.98% |
| Cash from Operations | 69.32% | 51.60% | 55.03% | 26.05% | -2.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -77.53% | -- | -- | -- | -- |
| Total Debt Repaid | 4.85% | 51.81% | 40.43% | -7,102.13% | -142,672.46% |
| Issuance of Common Stock | -93.35% | -88.58% | 19.73% | 3,915.02% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,432.63% | -109.29% | 2,339.76% | 1,302.33% | 7,316.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.20% | -195.25% | 106.37% | 28.91% | 8.94% |